Astellas Pharma is a global pharmaceutical company based in Japan. It was formed in 2005 through the merger of two companies, Yamanouchi Pharmaceutical and Seiko Pharmaceutical. Astellas focuses on developing innovative medicines in various therapeutic areas, including oncology, urology, and immunology. The company is committed to improving the health of patients worldwide by investing in research and development. Astellas operates in over 70 countries and collaborates with other organizations to advance healthcare solutions. Its mission is to contribute to the health of people around the globe through the creation of valuable pharmaceuticals.